Testing a blood clot test using whole blood flow
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests a new lab device that measures how well your body forms primary blood clots while blood is kept in flowing conditions. It may help doctors better assess bleeding or clotting tendencies and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to give oral consent (agree to take part after understanding).
- You must be an adult (not a child/teen).
- You must be either a blood donor at EFS Bourgogne Franche-Comté, or a patient followed for von Willebrand disease/bleeding conditions at the Dijon/Besançon center, or someone taking anti-platelet medicines who is being seen for a clotting problem at Dijon/Besançon hospital.
- You must be covered by national health insurance (be a beneficiary, not just uninsured).
- You must not be under court-ordered legal protection (such as guardianship/curatorship).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at cardiovascular problems and blood-clot events (like deep vein clots or pulmonary embolism) in adults with Von Willebrand disease in western France. It may help doctors better understand who is at risk and how to manage these complications.
This trial uses stored blood samples to see how well different lab tests measure clotting when someone has a factor deficiency (like low levels of clotting proteins) or liver damage. It may help doctors choose the most accurate test for these situations.
This trial compares different blood test reagents to see which works best for measuring clotting time in people with clotting factor deficiencies or liver disease. It may help doctors choose the right test for your condition.
This study looks at how well a blood test (PFA-200) works to check clotting in people who take different types of blood thinners. You don't need any extra procedures—just your regular blood draw.
This study measures how long it takes for your blood to clot while you are taking anticoagulant medication. The purpose is to understand typical clotting times for patients on these drugs, which may help improve future monitoring or treatment decisions.
This study tests a new blood test called ClotChek™ to see how well it works for people taking direct oral anticoagulants (DOACs), a type of blood thinner. You would give a blood sample, and the test may help doctors better monitor your medication.
Hear when a new Von Willebrand Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.